0000899243-19-027441.txt : 20191115 0000899243-19-027441.hdr.sgml : 20191115 20191115200332 ACCESSION NUMBER: 0000899243-19-027441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191114 FILED AS OF DATE: 20191115 DATE AS OF CHANGE: 20191115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weissman James B CENTRAL INDEX KEY: 0001598480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 191225941 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-14 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001598480 Weissman James B C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 EVP & Chief Operating Officer Common Stock 2019-11-14 4 M 0 20000 3.42 A 34704 D Common Stock 2019-11-14 4 S 0 20000 20.00 D 14704 D Employee Stock Option (Right to Buy) 3.42 2019-11-14 4 M 0 20000 0.00 D 2023-09-24 Common Stock 20000 40000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2018. This option vested 1/48 monthly on the last day of each month with a vesting start date of 7/30/2013. /s/ John B. Green, attorney-in-fact 2019-11-15